New lipid targets at odds with international standards.

The article focuses on the latest NICE guideline on Cardiovascular disease (CVD) risk assessment and reduction, particularly concerning lipid management targets, which has sparked debate within the Primary Care Cardiovascular Society (PCCS) regarding its alignment with other guidelines and its potential impact on reducing cardiovascular events.